<DOC>
	<DOC>NCT01186692</DOC>
	<brief_summary>The purpose of this study is to confirm the short-term hemodynamic effectiveness results achieved by real-world providers are equivalent to the historical control established in the IDE study.</brief_summary>
	<brief_title>Melody® Transcatheter Pulmonary Valve Post-Approval Study</brief_title>
	<detailed_description />
	<criteria>Existence of a full (circumferential) RVOT conduit that was equal to or greater than 16 mm in diameter when originally implanted Dysfunctional RVOT conduits with a clinical indication for intervention (regurgitation ≥ moderate regurgitation, Stenosis: mean RVOT gradient ≥ 35 mmHg) Implantation in the aortic or mitral position Venous anatomy unable to accommodate a 22fr size introducer sheath Obstruction of the central veins Clinical or biological signs of infection including active endocarditis Unwilling or unable to provide written informed consent or comply with the followup requirements</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>